leadf
logo-loader
viewKromek Group PLC

Kromek Group PLC - Notice of Results

RNS Number : 7302V
Kromek Group PLC
05 December 2019
 

5 December 2019 

 

Kromek Group plc

("Kromek" or the "Group")

 

Notice of Results

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, will be announcing its interim results for the six months ended 31 October 2019 on Wednesday 11 December 2019.

 

Dr. Arnab Basu, CEO, and Derek Bulmer, CFO, will be hosting a presentation to analysts at 9.30am GMT, on the day, at the offices of Luther Pendragon, 48 Gracechurch Street, London, EC3V 0EJ.

 

 

For further information, please contact:

 

Kromek Group plc


Arnab Basu, CEO

Derek Bulmer, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser)


Max Hartley (NOMAD)

Julian Morse (Sales)

 

+44 (0)20 7397 8900

Luther Pendragon Ltd (PR)


Harry Chathli

Claire Norbury

Alexis Gore

Joe Quinlan

+44 (0)20 7618 9100

 

 

About Kromek Group plc

 

Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

 

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over one hundred full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NORFSEFALFUSEDE

Quick facts: Kromek Group PLC

Price: 11.875

Market: AIM
Market Cap: £40.93 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Kromek Group CEO details DARPA extension and 'groundbreaking' pathogen...

Kromek Group PLC's (LON:KMK) Dr Arnab Basu speaks to Proactive London's Andrew Scott after reporting they've been awarded an extension to its contract with the Defense Advanced Research Projects Agency (DARPA) to detect and identify pathogens in an urban environment. Under the deal it will be...

on 27/5/20